# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001159036-24-000008
Filing Date
2024-02-20
Accepted
2024-02-20 16:07:29
Documents
120
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | halo-20231231.htm iXBRL | 10-K | 2208056
2 | EX-10.28 | ex1028severancepolicy.htm | EX-10.28 | 6255
3 | EX-21.1 | ex211subsidiaries2023.htm | EX-21.1 | 6150
4 | EX-23.1 | ex231auditorconsent2023.htm | EX-23.1 | 5653
5 | EX-31.1 | ex31110qq42023.htm | EX-31.1 | 12955
6 | EX-31.2 | ex31210qq42023.htm | EX-31.2 | 12895
7 | EX-32 | ex3210qq42023.htm | EX-32 | 13895
8 | EX-97 | ex97halozymetherapeuticsin.htm | EX-97 | 17164
14 | GRAPHIC | halo-20231231_g1.jpg | GRAPHIC | 15840
15 | GRAPHIC | halo-20231231_g2.jpg | GRAPHIC | 210702
16 | GRAPHIC | halo-20231231_g3.jpg | GRAPHIC | 65338
17 | GRAPHIC | halo-20231231_g4.jpg | GRAPHIC | 79428
| Complete submission text file | 0001159036-24-000008.txt |  | 13432993

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20231231.xsd | EX-101.SCH | 77463
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | halo-20231231_cal.xml | EX-101.CAL | 136906
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | halo-20231231_def.xml | EX-101.DEF | 439136
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20231231_lab.xml | EX-101.LAB | 1118585
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20231231_pre.xml | EX-101.PRE | 744655
122 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20231231_htm.xml | XML | 1988551

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32335 | Film No.: 24653283
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)